ClinicalTrials.Veeva
Menu

Find clinical trials for Alzheimer's Disease in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Cognitive Dysfunction
Dementia
Mental Disorders
Neurodegenerative Diseases
Brain Diseases
Nervous System Diseases

Alzheimer's Disease trials near Orlando, FL, USA:

A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's...

Active, not recruiting
Early Alzheimer's Disease
Drug: Placebo
Drug: CT1812

Phase 2

Cognition Therapeutics
Cognition Therapeutics

Orlando, Florida, United States and 50 other locations

the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's...

Enrolling
Alzheimer Disease
Device: Blood Brain Barrier (BBB) Disruption
InSightec
InSightec

Orlando, Florida, United States and 9 other locations

This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in p...

Enrolling
Alzheimer's Disease
Biological: VHB937
Other: Placebo

Phase 2

Novartis
Novartis

Winter Park, Florida, United States of America and 71 other locations

This study is to test LHP588 in persons who have mild to moderate Alzheimer's disease (AD) who have shown progressive mental declin...

Enrolling
Alzheimer Disease
Alzheimer Disease Due to P. Gingivalis
Drug: Placebo Drug
Drug: LHP588

Phase 2

Lighthouse Pharmaceuticals, Inc.

Orlando, Florida, United States and 38 other locations

This study will evaluate the efficacy and safety of trontinemab in participants with biomarker evidence of Alzheimer's Disease (AD)...

Enrolling
Alzheimer's Disease
Drug: Placebo
Drug: Trontinemab

Phase 3

Roche
Roche

Maitland, Florida, United States and 6 other locations

and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndr...

Enrolling
Prodromal Alzheimer's Disease
Alzheimer's Disease
Biological: ACI-24.060 at Dose A in Study Part 1a
Biological: ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b

Phase 1, Phase 2

AC Immune

Orlando, Florida, United States and 25 other locations

The study medicine GSK4527226 is being studied in participants with Alzheimer's Disease (AD) in study 219867 (the parent study, NCT...

Enrolling
Alzheimer's Disease
Drug: GSK4527226

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Maitland, Florida, United States and 32 other locations

Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elder...

Enrolling
Alzheimer's Disease
Drug: ABBV-1758
Drug: Placebo for ABBV-1758

Phase 1, Phase 2

AbbVie
AbbVie

Winter Park, Florida, United States and 12 other locations

on the change from baseline at 6 months in cerebrospinal fluid (CSF) microtubule-binding region (MTBR)-tau-243 in participants with early Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Drug: E2814
Drug: Lecanemab

Phase 2

Eisai
Eisai

Clermont, Florida, United States of America and 25 other locations

and efficacy of ONO-2020 in participants with mild to moderate Alzheimer's disease (AD). This study aims to determine whether admin ...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: ONO-2020

Phase 2

Ono Pharmaceutical Co., Ltd.

Orlando, Florida, United States and 82 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems